Genomics England Taps Medical Imaging Firm Sectra To Bolster Cancer Research
Genomics England, a UK government-owned genomic sequencing company, has joined forces with Swedish medical imaging and cybersecurity firm Sectra to “push the boundaries” of cancer research by linking up cancer images from NHS trusts data with genomics data and AI.
You may also be interested in...
EU Taps Power Of AI To Beat Cancer In New Imaging Initiative
The European Commission’s newly-launched Cancer Imaging Initiative will see sophisticated digital technologies based on artificial intelligence used to speed up medical innovations as part of its wider Beating Cancer Plan.
MedTech Europe Urges EU To Support European Health Data Space Proposal
The European Commission’s proposed Regulation on the European Health Data Space has been broadly met with optimism by MedTech Europe. While some fine-tuning is needed, the trade body believes the initiative will help align health data across the EU.
Huma Secures EU MDR Approval For Medtech Software That Can Be Used In Any Disease
Huma Therapeutics has secured the first ever EU regulatory approval for a “disease agnostic” class IIb medtech software platform. CEO Dan Vahdat tells Medtech Insight how the product can be configured to monitor patients with any condition.